83_FR_55589 83 FR 55375 - National Institute on Drug Abuse; Notice of Closed Meeting

83 FR 55375 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 214 (November 5, 2018)

Page Range55375-55376
FR Document2018-24100

Federal Register, Volume 83 Issue 214 (Monday, November 5, 2018) 
[Federal Register Volume 83, Number 214 (Monday, November 5, 2018)]
[Notices]
[Pages 55375-55376]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-24100]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which

[[Page 55376]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Quantification of Drugs of Abuse and Related 
Compounds in Biological Specimens (8951).
    Date: December 6, 2018.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: October 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24100 Filed 11-2-18; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 214 / Monday, November 5, 2018 / Notices 55375 other than their time. The total estimated annualized burden hours are 13,297. ESTIMATED ANNUALIZED BURDEN HOURS Number of Average time/ Number of Total annual Type of respondent responses per response respondents burden hours respondent (hours) High School Scientific Training & Enrichment Program—Orientation ............. 25 1 10/60 4 High School Scientific Training & Enrichment Program 2.0—Orientation ...... 25 1 10/60 4 HiSTEP & HiSTEP2—Alumni Tracking ........................................................... 125 2 30/60 125 Summer Internship Program—Application ...................................................... 8,000 1 45/60 6,000 Summer Internship Program—Recommendation Letters ................................ 16,000 1 10/60 2,667 Amgen Scholars at NIH—Supplemental Application ....................................... 535 1 10/60 89 Amgen Scholars at NIH—Feedback ................................................................ 20 1 15/60 5 Amgen Scholars at NIH—Alumni Tracking ..................................................... 127 1 30/60 64 Community College Summer Enrichment Program—Alumni Tracking ........... 158 1 10/60 26 College—Summer Opportunities in Advanced Research—Alumni Tracking .. 158 1 10/60 26 Graduate—Summer Opportunities in Advanced Research—Alumni Tracking 114 1 30/60 57 Graduate Data Science Summer Program—Alumni Tracking ........................ 30 1 30/60 15 Native American Visit Week—Application ....................................................... 15 1 20/60 5 Native American Visit Week—Recommendation Letters ................................ 15 1 10/60 3 Native American Visit Week—Feedback ......................................................... 15 1 15/60 4 Undergraduate Scholarship Program—Application ......................................... 125 1 60/60 125 Undergraduate Scholarship Program—Recommendation Letters for Appli- cants ............................................................................................................. 375 1 10/60 63 Undergraduate Scholarship Program—Exceptional Financial Need—Com- pleted by Applicant ....................................................................................... 125 1 3/60 8 Undergraduate Scholarship Program—Exceptional Financial Need—Com- pleted by University Staff ............................................................................. 125 1 15/60 41 Undergraduate Scholarship Program—Exceptional Financial Need Resub- mission—Completed by Applicant ............................................................... 38 1 3/60 8 Undergraduate Scholarship Program—Exceptional Financial Need Resub- mission—Completed by University Staff ...................................................... 38 1 15/60 41 Undergraduate Scholarship Program—Scholar Contract ................................ 25 1 10/60 4 Undergraduate Scholarship Program—Evaluation of Scholar Pay Back Pe- riod ............................................................................................................... 30 1 15/60 8 Undergraduate Scholarship Program—Renewal Application .......................... 15 1 45/60 11 Undergraduate Scholarship Program—Recommendation Letters for Renew- als ................................................................................................................. 15 1 10/60 3 Undergraduate Scholarship Program—Deferment Form—Completed by Scholar ......................................................................................................... 10 1 3/60 1 Undergraduate Scholarship Program—Deferment Form—Completed by Uni- versity Staff .................................................................................................. 10 1 12/60 2 Postbaccalaureate Training Program—Application ......................................... 2,250 1 45/60 1,688 Postbaccalaureate Training Program—Recommendation Letters .................. 6,750 1 10/60 1,125 NIH Academy—Fellow & Certificate Programs Application ............................ 300 1 15/60 75 NIH Academy—Enrichment Program Application ........................................... 175 1 15/60 44 Graduate Partnerships Program—Application ................................................. 325 1 60/60 325 Graduate Partnerships Program—Recommendation Letters for Application .. 975 1 10/60 163 Graduate Partnerships Program—Interview Experience Survey .................... 30 1 10/60 5 Graduate Partnerships Program—Registration ............................................... 175 1 15/60 44 Graduate Partnerships Program—Awards Certificate ..................................... 75 1 30/60 38 MyOITE—User Accounts ................................................................................. 6,000 1 3/60 300 MyOITE—NIH Alumni ...................................................................................... 500 1 15/60 125 OITE Careers Blog—Success Stories ............................................................. 6 1 45/60 5 Totals ........................................................................................................ 43,854 43,979 N/A 13,297 Dated: October 29, 2018. DEPARTMENT OF HEALTH AND The meeting will be closed to the Lawrence A. Tabak, HUMAN SERVICES public in accordance with the Deputy Director, National Institutes of Health. provisions set forth in sections [FR Doc. 2018–24150 Filed 11–2–18; 8:45 am] National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., BILLING CODE 4140–01–P as amended. The contract proposals and National Institute on Drug Abuse; the discussions could disclose Notice of Closed Meeting confidential trade secrets or commercial property such as patentable material, Pursuant to section 10(d) of the and personal information concerning Federal Advisory Committee Act, as individuals associated with the contract amended, notice is hereby given of the proposals, the disclosure of which following meeting. VerDate Sep<11>2014 18:38 Nov 02, 2018 Jkt 247001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\05NON1.SGM 05NON1

55376 Federal Register / Vol. 83, No. 214 / Monday, November 5, 2018 / Notices would constitute a clearly unwarranted Room 7009, 6707 Democracy Boulevard, this notice. The statement should include the invasion of personal privacy. Bethesda, MD 20892–5452, 301–594–4721, name, address, telephone number and when Kozelp@niddk.nih.gov. applicable, the business or professional Name of Committee: National Institute on affiliation of the interested person. Drug Abuse Special Emphasis Panel; (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, In the interest of security, NIH has Quantification of Drugs of Abuse and Related instituted stringent procedures for entrance Compounds in Biological Specimens (8951). Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition onto the NIH campus. All visitor vehicles, Date: December 6, 2018. including taxicabs, hotel and airport shuttles Time: 11:00 a.m. to 1:00 p.m. Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes will be inspected before being allowed on Agenda: To review and evaluate contract of Health, HHS) campus. Visitors will be asked to show one proposals. form of identification (for example, a Place: National Institutes of Health, Dated: October 30, 2018. government-issued photo ID, driver’s license, Neuroscience Center, 6001 Executive David D. Clary, Boulevard, Rockville, MD 20852 (Telephone or passport) and to state the purpose of their Conference Call). Program Analyst, Office of Federal Advisory visit. Contact Person: Lyle Furr, Scientific Committee Policy. Information is also available on the Review Officer, Office of Extramural Affairs, [FR Doc. 2018–24098 Filed 11–2–18; 8:45 am] Institute’s/Center’s home page: http:// National Institute on Drug Abuse, NIH, acd.od.nih.gov, where an agenda and any BILLING CODE 4140–01–P DHHS, Room 4227, MSC 9550, 6001 additional information for the meeting will Executive Boulevard, Bethesda, MD 20892– be posted when available. 9550, (301) 827–5702, lf33c.nih.gov. DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research HUMAN SERVICES Training Award; 93.22, Clinical Research Program No.: 93.279, Drug Abuse and Addiction Research Programs, National Loan Repayment Program for Individuals National Institutes of Health from Disadvantaged Backgrounds; 93.232, Institutes of Health, HHS) Loan Repayment Program for Research Dated: October 30, 2018. Office of the Director, National Generally; 93.39, Academic Research Natasha M. Copeland, Institutes of Health; Notice of Meeting Enhancement Award; 93.936, NIH Acquired Program Analyst, Office of Federal Advisory Pursuant to section 10(a) of the Immunodeficiency Syndrome Research Loan Committee Policy. Federal Advisory Committee Act, as Repayment Program; 93.187, Undergraduate [FR Doc. 2018–24100 Filed 11–2–18; 8:45 am] Scholarship Program for Individuals from amended, notice is hereby given of a Disadvantaged Backgrounds, National BILLING CODE 4140–01–P meeting of the Advisory Committee to Institutes of Health, HHS) the Director, National Institutes of Health. Dated: October 30, 2018. DEPARTMENT OF HEALTH AND The meeting will be open to the Natasha M. Copeland, HUMAN SERVICES public, with attendance limited to space Program Analyst, Office of Federal Advisory available. Individuals who plan to Committee Policy. National Institutes of Health attend and need special assistance, such [FR Doc. 2018–24097 Filed 11–2–18; 8:45 am] National Institute of Diabetes and as sign language interpretation or other BILLING CODE 4140–01–P Digestive and Kidney Diseases; Notice reasonable accommodations, should of Closed Meeting notify the Contact Person listed below in advance of the meeting. DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the HUMAN SERVICES Name of Committee: Advisory Committee Federal Advisory Committee Act, as to the Director, National Institutes of Health. amended, notice is hereby given of the National Institutes of Health Date: December 13, 2018. following meeting. Time: 8:30 a.m. to 5:30 p.m. The meeting will be closed to the Center for Scientific Review; Notice of Agenda: NIH Director’s Report, ACD public in accordance with the Working Group Reports, Other Business of Closed Meetings provisions set forth in sections the Committee. Pursuant to section 10(d) of the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: National Institutes of Health. Federal Advisory Committee Act, as as amended. The grant applications and Building 31, 6th Floor Conference Room 6C, 31 Center Drive, Bethesda, MD 20892. amended, notice is hereby given of the the discussions could disclose following meetings. Contact Person: Gretchen Wood, Staff confidential trade secrets or commercial The meetings will be closed to the Assistant, National Institutes of Health, property such as patentable material, Office of the Director, One Center Drive, public in accordance with the and personal information concerning Building 1, Room 126, Bethesda, MD 20892, provisions set forth in sections individuals associated with the grant 301–496–4272, Woodgs@od.nih.gov. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications, the disclosure of which Name of Committee: Advisory Committee as amended. The grant applications and would constitute a clearly unwarranted to the Director, National Institutes of Health. the discussions could disclose invasion of personal privacy. Date: December 14, 2018. confidential trade secrets or commercial Name of Committee: National Institute of Time: 9:00 a.m. to 12:30 p.m. property such as patentable material, Diabetes and Digestive and Kidney Diseases Agenda: ACD Working Group Reports, and personal information concerning Special Emphasis Panel; NIDDK SEP: RC2. Other Business of the Committee. individuals associated with the grant Date: November 19, 2018. Place: National Institutes of Health, Building 31, 6th Floor Conference Room 6C, applications, the disclosure of which Time: 2:00 p.m. to 3:30 p.m. would constitute a clearly unwarranted Agenda: To review and evaluate grant 31 Center Drive, Bethesda, MD 20892. Contact Person: Gretchen Wood, Staff invasion of personal privacy. applications. Place: National Institutes of Health, Two Assistant, National Institutes of Health, Name of Committee: Center for Scientific Democracy Plaza, 6707 Democracy Office of the Director, One Center Drive, Review Special Emphasis Panel; Boulevard, Bethesda, MD 20892 (Telephone Building 1, Room 126, Bethesda, MD 20892, Cardiovascular Disease. Conference Call) 301–496–4272, Woodgs@od.nih.gov. Date: November 13, 2018. Contact Person: Peter J. Kozel, Ph.D., Any interested person may file written Time: 2:00 p.m. to 4:00 p.m. Scientific Review Officer, Review Branch, comments with the committee by forwarding Agenda: To review and evaluate grant DEA, NIDDK, National Institutes of Health, the statement to the Contact Person listed on applications. VerDate Sep<11>2014 18:38 Nov 02, 2018 Jkt 247001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\05NON1.SGM 05NON1


Document Created: 2018-11-03 00:28:16
Document Modified: 2018-11-03 00:28:16
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesDecember 6, 2018.
FR Citation83 FR 55375 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR